Transcriptome-Wide Analysis of Hepatitis B Virus-Mediated Changes to Normal Hepatocyte Gene Expression

PLoS Pathogens

Volumn 12, Issue 2, 2016, Pages

  Lamontagne, Jason ^a   Mell, Joshua C ^a   Bouchard, Michael J ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2; CYCLIN E; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 2; GREEN FLUORESCENT PROTEIN; MICRORNA; TRANSCRIPTOME;

ADENOVIRUS INFECTION; ANIMAL CELL; ARTICLE; CELL CYCLE REGULATION; CELL METABOLISM; COMPARATIVE STUDY; CONTROLLED STUDY; GENE EXPRESSION; GENE MAPPING; GENETIC ASSOCIATION; GENETIC TRANSFECTION; HEPATITIS B; HEPATITIS B VIRUS; LIPOGENESIS; LIVER CELL; NEOPLASM; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; SIGNAL TRANSDUCTION; SOUTHERN BLOTTING; VIRUS REPLICATION; ANIMAL; DNA REPLICATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; LIVER TUMOR; METABOLISM; PROCEDURES; RAT; VIROLOGY;

ANIMALS; DNA REPLICATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, VIRAL; HEPATITIS B; HEPATITIS B VIRUS; HEPATOCYTES; HOST-PATHOGEN INTERACTIONS; HUMANS; LIVER NEOPLASMS; RATS; SIGNAL TRANSDUCTION; TRANSCRIPTOME; VIRUS REPLICATION;

EID: 84959457692     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005438     Document Type: Article

References (115)

1. El-Serag HB, Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142(6):1264–73 e1. doi: 10.1053/j.gastro.2011.12.06122537432
2. Block TM, Mehta AS, Fimmel CJ, Jordan R, Molecular viral oncology of hepatocellular carcinoma. Oncogene. 2003;22(33):5093–107. Epub 2003/08/12. 12910247
3. Scaglione SJ, Lok AS, Effectiveness of hepatitis B treatment in clinical practice. Gastroenterology. 2012;142(6):1360–8 e1. doi: 10.1053/j.gastro.2012.01.04422537444
4. GLOBOCAN 2012 v1.0 [Internet]. IARC CancerBase No. 11. 2013. Available from: http://globocan.iarc.fr.
5. Gish RG, Given BD, Lai CL, Locarnini SA, Lau JY, Lewis DL, et al. Chronic hepatitis B: virology, natural history, current management and a glimpse at future opportunities. Antiviral research. 2015.
6. Steer CJ, Liver regeneration. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 1995;9(14):1396–400.
7. Gearhart TL, Bouchard MJ, The hepatitis B virus X protein modulates hepatocyte proliferation pathways to stimulate viral replication. Journal of virology. 2010;84(6):2675–86. Epub 2010/01/08. doi: 10.1128/JVI.02196-0920053744
8. Gearhart TL, Bouchard MJ, The hepatitis B virus HBx protein modulates cell cycle regulatory proteins in cultured primary human hepatocytes. Virus research. 2011;155(1):363–7. Epub 2010/10/12. doi: 10.1016/j.virusres.2010.09.02320934470
9. Bouchard M, Giannakopoulos S, Wang EH, Tanese N, Schneider RJ, Hepatitis B virus HBx protein activation of cyclin A-cyclin-dependent kinase 2 complexes and G1 transit via a Src kinase pathway. Journal of virology. 2001;75(9):4247–57. 11287574
10. Benn J, Schneider RJ, Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls. Proceedings of the National Academy of Sciences of the United States of America. 1995;92(24):11215–9. 7479968
11. Ludgate L, Ning X, Nguyen DH, Adams C, Mentzer L, Hu J, Cyclin-dependent kinase 2 phosphorylates s/t-p sites in the hepadnavirus core protein C-terminal domain and is incorporated into viral capsids. Journal of virology. 2012;86(22):12237–50. doi: 10.1128/JVI.01218-1222951823
12. Ahn JY, Chung EY, Kwun HJ, Jang KL, Transcriptional repression of p21(waf1) promoter by hepatitis B virus X protein via a p53-independent pathway. Gene. 2001;275(1):163–8. 11574165
13. Chin R, Earnest-Silveira L, Koeberlein B, Franz S, Zentgraf H, Dong X, et al. Modulation of MAPK pathways and cell cycle by replicating hepatitis B virus: factors contributing to hepatocarcinogenesis. Journal of hepatology. 2007;47(3):325–37. 17512084
14. Lee S, Tarn C, Wang WH, Chen S, Hullinger RL, Andrisani OM, Hepatitis B virus X protein differentially regulates cell cycle progression in X-transforming versus nontransforming hepatocyte (AML12) cell lines. The Journal of biological chemistry. 2002;277(10):8730–40. 11756437
15. Mukherji A, Janbandhu VC, Kumar V, HBx-dependent cell cycle deregulation involves interaction with cyclin E/A-cdk2 complex and destabilization of p27Kip1. The Biochemical journal. 2007;401(1):247–56. 16939421
16. Song CL, Ren JH, Ran LK, Li YG, Li XS, Chen X, et al. Cyclin D2 plays a regulatory role in HBV replication. Virology. 2014;462–463:149–57. doi: 10.1016/j.virol.2014.05.02724992041
17. Bagga S, Bouchard MJ, Cell cycle regulation during viral infection. Methods Mol Biol. 2014;1170:165–227. doi: 10.1007/978-1-4939-0888-2_1024906315
18. Casciano J, Bagga S, Yang B, Bouchard MJ. Modulation of cell proliferation pathways by the hepatitis B virus X protein: a potential contributor to the development of hepatocellular carcinoma. 2011.
19. Guo H, Zhou T, Jiang D, Cuconati A, Xiao GH, Block TM, et al. Regulation of hepatitis B virus replication by the phosphatidylinositol 3-kinase-akt signal transduction pathway. Journal of virology. 2007;81(18):10072–80. Epub 2007/07/05. 17609269
20. Rawat S, Bouchard M, The Hepatitis B Virus HBx protein activates AKT to simultaneously regulate HBV replication and hepatocyte survival. Journal of virology. 2014.
21. Teng CF, Hsieh WC, Wu HC, Lin YJ, Tsai HW, Huang W, et al. Hepatitis B Virus Pre-S2 Mutant Induces Aerobic Glycolysis through Mammalian Target of Rapamycin Signal Cascade. PloS one. 2015;10(4):e0122373. doi: 10.1371/journal.pone.012237325909713
22. Xu X, Fan Z, Kang L, Han J, Jiang C, Zheng X, et al. Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis. The Journal of clinical investigation. 2013. Epub 2013/01/17.
23. Zhu M, Guo J, Li W, Lu Y, Fu S, Xie X, et al. Hepatitis B virus X protein induces expression of alpha-fetoprotein and activates PI3K/mTOR signaling pathway in liver cells. Oncotarget. 2015.
24. Teng CF, Wu HC, Tsai HW, Shiah HS, Huang W, Su IJ, Novel feedback inhibition of surface antigen synthesis by mammalian target of rapamycin (mTOR) signal and its implication for hepatitis B virus tumorigenesis and therapy. Hepatology. 2011;54(4):1199–207. doi: 10.1002/hep.2452921735472
25. Bouchard MJ, Wang L, Schneider RJ, Activation of focal adhesion kinase by hepatitis B virus HBx protein: multiple functions in viral replication. Journal of virology. 2006;80(9):4406–14. 16611900
26. Tarn C, Lee S, Hu Y, Ashendel C, Andrisani OM, Hepatitis B virus X protein differentially activates RAS-RAF-MAPK and JNK pathways in X-transforming versus non-transforming AML12 hepatocytes. The Journal of biological chemistry. 2001;276(37):34671–80. 11461911
27. Liu WH, Yeh SH, Chen PJ, Role of microRNAs in hepatitis B virus replication and pathogenesis. Biochimica et biophysica acta. 2011;1809(11–12):678–85. Epub 2011/05/14. doi: 10.1016/j.bbagrm.2011.04.00821565290
28. Thirion M, Ochiya T, Roles of microRNAs in the Hepatitis B Virus Infection and Related Diseases. Viruses. 2013;5(11):2690–703. doi: 10.3390/v511269024212236
29. Lamontagne J, Steel LF, Bouchard MJ, Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases. World journal of gastroenterology: WJG. 2015;21(24):7375–99. doi: 10.3748/wjg.v21.i24.737526139985
30. Fletcher SP, Chin DJ, Ji Y, Iniguez AL, Taillon B, Swinney DC, et al. Transcriptomic analysis of the woodchuck model of chronic hepatitis B. Hepatology. 2012;56(3):820–30. doi: 10.1002/hep.2573022431061
31. Huang Q, Lin B, Liu H, Ma X, Mo F, Yu W, et al. RNA-Seq analyses generate comprehensive transcriptomic landscape and reveal complex transcript patterns in hepatocellular carcinoma. PloS one. 2011;6(10):e26168. doi: 10.1371/journal.pone.002616822043308
32. Yu Y, Fuscoe JC, Zhao C, Guo C, Jia M, Qing T, et al. A rat RNA-Seq transcriptomic BodyMap across 11 organs and 4 developmental stages. Nature communications. 2014;5:3230. doi: 10.1038/ncomms423024510058
33. Chapple RH, Tizioto PC, Wells KD, Givan SA, Kim J, McKay SD, et al. Characterization of the rat developmental liver transcriptome. Physiol Genomics. 2013;45(8):301–11. doi: 10.1152/physiolgenomics.00128.201223429212
34. Jagya N, Varma SP, Thakral D, Joshi P, Durgapal H, Panda SK, RNA-seq based transcriptome analysis of hepatitis E virus (HEV) and hepatitis B virus (HBV) replicon transfected Huh-7 cells. PloS one. 2014;9(2):e87835. doi: 10.1371/journal.pone.008783524505321
35. Lin KT, Shann YJ, Chau GY, Hsu CN, Huang CY, Identification of latent biomarkers in hepatocellular carcinoma by ultra-deep whole-transcriptome sequencing. Oncogene. 2013. Epub 2013/10/22.
36. Merrick BA, Phadke DP, Auerbach SS, Mav D, Stiegelmeyer SM, Shah RR, et al. RNA-Seq profiling reveals novel hepatic gene expression pattern in aflatoxin B1 treated rats. PloS one. 2013;8(4):e61768. doi: 10.1371/journal.pone.006176823630614
37. Tyakht AV, Ilina EN, Alexeev DG, Ischenko DS, Gorbachev AY, Semashko TA, et al. RNA-Seq gene expression profiling of HepG2 cells: the influence of experimental factors and comparison with liver tissue. BMC genomics. 2014;15:1108. doi: 10.1186/1471-2164-15-110825511409
38. Fletcher SP, Chin DJ, Cheng DT, Ravindran P, Bitter H, Gruenbaum L, et al. Identification of an intrahepatic transcriptional signature associated with self-limiting infection in the woodchuck model of hepatitis B. Hepatology. 2013;57(1):13–22. doi: 10.1002/hep.2595422806943
39. Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J, Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer research. 1982;42(9):3858–63. 6286115
40. Knowles BB, Howe CC, Aden DP, Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science. 1980;209(4455):497–9. 6248960
41. Boess F, Kamber M, Romer S, Gasser R, Muller D, Albertini S, et al. Gene expression in two hepatic cell lines, cultured primary hepatocytes, and liver slices compared to the in vivo liver gene expression in rats: possible implications for toxicogenomics use of in vitro systems. Toxicol Sci. 2003;73(2):386–402. 12657743
42. Gripon P, Diot C, Theze N, Fourel I, Loreal O, Brechot C, et al. Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide. Journal of virology. 1988;62(11):4136–43. 3172341
43. Kock J, Nassal M, MacNelly S, Baumert TF, Blum HE, von Weizsacker F, Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus. Journal of virology. 2001;75(11):5084–9. 11333889
44. Gripon P, Rumin S, Urban S, Le Seyec J, Glaise D, Cannie I, et al. Infection of a human hepatoma cell line by hepatitis B virus. Proceedings of the National Academy of Sciences of the United States of America. 2002;99(24):15655–60. Epub 2002/11/15. 12432097
45. Galle PR, Hagelstein J, Kommerell B, Volkmann M, Schranz P, Zentgraf H, In vitro experimental infection of primary human hepatocytes with hepatitis B virus. Gastroenterology. 1994;106(3):664–73. 8119538
46. Clippinger AJ, Gearhart TL, Bouchard MJ, Hepatitis B virus X protein modulates apoptosis in primary rat hepatocytes by regulating both NF-kappaB and the mitochondrial permeability transition pore. Journal of virology. 2009;83(10):4718–31. Epub 2009/03/13. doi: 10.1128/JVI.02590-0819279112
47. Sprinzl MF, Oberwinkler H, Schaller H, Protzer U, Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier. Journal of virology. 2001;75(11):5108–18. 11333892
48. Gearhart TL, Bouchard MJ, Replication of the hepatitis B virus requires a calcium-dependent HBx-induced G1 phase arrest of hepatocytes. Virology. 2010;407(1):14–25. Epub 2010/08/20. doi: 10.1016/j.virol.2010.07.04220719353
49. Kajino K, Jilbert AR, Saputelli J, Aldrich CE, Cullen J, Mason WS, Woodchuck hepatitis virus infections: very rapid recovery after a prolonged viremia and infection of virtually every hepatocyte. Journal of virology. 1994;68(9):5792–803. 7914548
50. Wieland SF, Spangenberg HC, Thimme R, Purcell RH, Chisari FV, Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees. Proceedings of the National Academy of Sciences of the United States of America. 2004;101(7):2129–34. 14764900
51. Seeger C, Ganem D, Varmus HE, Biochemical and genetic evidence for the hepatitis B virus replication strategy. Science. 1986;232(4749):477–84. 3961490
52. Perfumo S, Amicone L, Colloca S, Giorgio M, Pozzi L, Tripodi M, Recognition efficiency of the hepatitis B virus polyadenylation signals is tissue specific in transgenic mice. Journal of virology. 1992;66(11):6819–23. 1357192
53. Vellinga J, Van der Heijdt S, Hoeben RC, The adenovirus capsid: major progress in minor proteins. The Journal of general virology. 2005;86(Pt 6):1581–8. 15914835
54. Shapiro GS, Van Peursem C, Ornelles DA, Schaack J, DeGregori J, Recombinant adenoviral vectors can induce expression of p73 via the E4-orf6/7 protein. Journal of virology. 2006;80(11):5349–60. 16699015
55. Assogba BD, Choi BH, Rho HM, Transcriptional activation of the promoter of human cytomegalovirus immediate early gene (CMV-IE) by the hepatitis B viral X protein (HBx) through the NF-kappaB site. Virus research. 2002;84(1–2):171–9. 11900849
56. Qiao L, Leach K, McKinstry R, Gilfor D, Yacoub A, Park JS, et al. Hepatitis B virus X protein increases expression of p21(Cip-1/WAF1/MDA6) and p27(Kip-1) in primary mouse hepatocytes, leading to reduced cell cycle progression. Hepatology. 2001;34(5):906–17. 11679961
57. Toyama T, Lee HC, Koga H, Wands JR, Kim M, Noncanonical Wnt11 inhibits hepatocellular carcinoma cell proliferation and migration. Mol Cancer Res. 2010;8(2):254–65. doi: 10.1158/1541-7786.MCR-09-023820103596
58. Welch C, Santra MK, El-Assaad W, Zhu X, Huber WE, Keys RA, et al. Identification of a protein, G0S2, that lacks Bcl-2 homology domains and interacts with and antagonizes Bcl-2. Cancer research. 2009;69(17):6782–9. doi: 10.1158/0008-5472.CAN-09-012819706769
59. Zechner R, Zimmermann R, Eichmann TO, Kohlwein SD, Haemmerle G, Lass A, et al. FAT SIGNALS—lipases and lipolysis in lipid metabolism and signaling. Cell metabolism. 2012;15(3):279–91. doi: 10.1016/j.cmet.2011.12.01822405066
60. Wang Y, Zhang Y, Qian H, Lu J, Zhang Z, Min X, et al. The g0/g1 switch gene 2 is an important regulator of hepatic triglyceride metabolism. PloS one. 2013;8(8):e72315. doi: 10.1371/journal.pone.007231523951308
61. Heckmann BL, Zhang X, Xie X, Liu J, The G0/G1 switch gene 2 (G0S2): regulating metabolism and beyond. Biochimica et biophysica acta. 2013;1831(2):276–81. doi: 10.1016/j.bbalip.2012.09.01623032787
62. Wolfrum N, Greber UF, Adenovirus signalling in entry. Cellular microbiology. 2013;15(1):53–62. doi: 10.1111/cmi.1205323083122
63. Alberti A, Belser C, Engelen S, Bertrand L, Orvain C, Brinas L, et al. Comparison of library preparation methods reveals their impact on interpretation of metatranscriptomic data. BMC genomics. 2014;15:912. doi: 10.1186/1471-2164-15-91225331572
64. Draghici S, Khatri P, Tarca AL, Amin K, Done A, Voichita C, et al. A systems biology approach for pathway level analysis. Genome research. 2007;17(10):1537–45. 17785539
65. Meerzaman DM, Yan C, Chen QR, Edmonson MN, Schaefer CF, Clifford RJ, et al. Genome-wide transcriptional sequencing identifies novel mutations in metabolic genes in human hepatocellular carcinoma. Cancer genomics & proteomics. 2014;11(1):1–12.
66. Coppola N, Potenza N, Pisaturo M, Mosca N, Tonziello G, Signoriello G, et al. Liver microRNA hsa-miR-125a-5p in HBV chronic infection: correlation with HBV replication and disease progression. PloS one. 2013;8(7):e65336. doi: 10.1371/journal.pone.006533623843939
67. Park SO, Kumar M, Gupta S, TGF-beta and iron differently alter HBV replication in human hepatocytes through TGF-beta/BMP signaling and cellular microRNA expression. PloS one. 2012;7(6):e39276. doi: 10.1371/journal.pone.003927622723983
68. Potenza N, Papa U, Mosca N, Zerbini F, Nobile V, Russo A, Human microRNA hsa-miR-125a-5p interferes with expression of hepatitis B virus surface antigen. Nucleic acids research. 2011;39(12):5157–63. Epub 2011/02/15. doi: 10.1093/nar/gkr06721317190
69. Hou J, Lin L, Zhou W, Wang Z, Ding G, Dong Q, et al. Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer cell. 2011;19(2):232–43. Epub 2011/02/15. doi: 10.1016/j.ccr.2011.01.00121316602
70. Guo H, Liu H, Mitchelson K, Rao H, Luo M, Xie L, et al. MicroRNAs-372/373 promote the expression of hepatitis B virus through the targeting of nuclear factor I/B. Hepatology. 2011;54(3):808–19. Epub 2011/05/25. doi: 10.1002/hep.2444121608007
71. Jin J, Tang S, Xia L, Du R, Xie H, Song J, et al. MicroRNA-501 promotes HBV replication by targeting HBXIP. Biochemical and biophysical research communications. 2013;430(4):1228–33. Epub 2012/12/26. doi: 10.1016/j.bbrc.2012.12.07123266610
72. Wang Y, Lu Y, Toh ST, Sung WK, Tan P, Chow P, et al. Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3. Journal of hepatology. 2010;53(1):57–66. Epub 2010/05/08. doi: 10.1016/j.jhep.2009.12.04320447714
73. Zhang ZZ, Liu X, Wang DQ, Teng MK, Niu LW, Huang AL, et al. Hepatitis B virus and hepatocellular carcinoma at the miRNA level. World journal of gastroenterology: WJG. 2011;17(28):3353–8. Epub 2011/08/31. doi: 10.3748/wjg.v17.i28.335321876625
74. Xu G, Gao Z, He W, Ma Y, Feng X, Cai T, et al. microRNA expression in hepatitis B virus infected primary treeshrew hepatocytes and the independence of intracellular miR-122 level for de novo HBV infection in culture. Virology. 2014;448:247–54. doi: 10.1016/j.virol.2013.10.01624314655
75. Liu Y, Zhao JJ, Wang CM, Li MY, Han P, Wang L, et al. Altered expression profiles of microRNAs in a stable hepatitis B virus-expressing cell line. Chinese medical journal. 2009;122(1):10–4. Epub 2009/02/04. 19187610
76. Zhang X, Zhang E, Ma Z, Pei R, Jiang M, Schlaak JF, et al. Modulation of hepatitis B virus replication and hepatocyte differentiation by MicroRNA-1. Hepatology. 2011;53(5):1476–85. Epub 2011/04/27. doi: 10.1002/hep.2419521520166
77. Auth MK, Okamoto M, Ishida Y, Keogh A, Auth SH, Gerlach J, et al. Maintained function of primary human hepatocytes by cellular interactions in coculture: implications for liver support systems. Transpl Int. 1998;11Suppl 1:S439–43. 9665034
78. Loyer P, Cariou S, Glaise D, Bilodeau M, Baffet G, Guguen-Guillouzo C, Growth factor dependence of progression through G1 and S phases of adult rat hepatocytes in vitro. Evidence of a mitogen restriction point in mid-late G1. The Journal of biological chemistry. 1996;271(19):11484–92. 8626707
79. Michalopoulos GK, DeFrances MC, Liver regeneration. Science. 1997;276(5309):60–6. 9082986
80. Wilkening S, Stahl F, Bader A, Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties. Drug Metab Dispos. 2003;31(8):1035–42. 12867492
81. Boni C, Fisicaro P, Valdatta C, Amadei B, Di Vincenzo P, Giuberti T, et al. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. Journal of virology. 2007;81(8):4215–25. 17287266
82. Bingle CD, Seal RL, Craven CJ, Systematic nomenclature for the PLUNC/PSP/BSP30/SMGB proteins as a subfamily of the BPI fold-containing superfamily. Biochem Soc Trans. 2011;39(4):977–83. doi: 10.1042/BST039097721787333
83. Bingle CD, Bingle L, Craven CJ, Distant cousins: genomic and sequence diversity within the BPI fold-containing (BPIF)/PLUNC protein family. Biochem Soc Trans. 2011;39(4):961–5. doi: 10.1042/BST039096121787330
84. Bremer CM, Bung C, Kott N, Hardt M, Glebe D, Hepatitis B virus infection is dependent on cholesterol in the viral envelope. Cellular microbiology. 2009;11(2):249–60. doi: 10.1111/j.1462-5822.2008.01250.x19016777
85. Dorobantu C, Macovei A, Lazar C, Dwek RA, Zitzmann N, Branza-Nichita N, Cholesterol depletion of hepatoma cells impairs hepatitis B virus envelopment by altering the topology of the large envelope protein. Journal of virology. 2011;85(24):13373–83. doi: 10.1128/JVI.05423-1121994451
86. Wieland S, Thimme R, Purcell RH, Chisari FV, Genomic analysis of the host response to hepatitis B virus infection. Proceedings of the National Academy of Sciences of the United States of America. 2004;101(17):6669–74. 15100412
87. Molina-Jimenez F, Benedicto I, Murata M, Martin-Vilchez S, Seki T, Antonio Pintor-Toro J, et al. Expression of pituitary tumor-transforming gene 1 (PTTG1)/securin in hepatitis B virus (HBV)-associated liver diseases: evidence for an HBV X protein-mediated inhibition of PTTG1 ubiquitination and degradation. Hepatology. 2010;51(3):777–87. doi: 10.1002/hep.2346820198633
88. Zhang Z, Zhang JY, Wherry EJ, Jin B, Xu B, Zou ZS, et al. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B. Gastroenterology. 2008;134(7):1938–49, 49 e1-3. doi: 10.1053/j.gastro.2008.03.03718455515
89. Jovanovic M, Rooney MS, Mertins P, Przybylski D, Chevrier N, Satija R, et al. Immunogenetics. Dynamic profiling of the protein life cycle in response to pathogens. Science. 2015;347(6226):1259038. doi: 10.1126/science.125903825745177
90. La Rocca G, Olejniczak SH, Gonzalez AJ, Briskin D, Vidigal JA, Spraggon L, et al. In vivo, Argonaute-bound microRNAs exist predominantly in a reservoir of low molecular weight complexes not associated with mRNA. Proceedings of the National Academy of Sciences of the United States of America. 2015;112(3):767–72. doi: 10.1073/pnas.142421711225568082
91. Olejniczak SH, La Rocca G, Gruber JJ, Thompson CB, Long-lived microRNA-Argonaute complexes in quiescent cells can be activated to regulate mitogenic responses. Proceedings of the National Academy of Sciences of the United States of America. 2013;110(1):157–62. doi: 10.1073/pnas.121995811023248281
92. Grisham J, Arias IM, Organizational Principles in the Liver. In: The Liver Biology and Pathobiology. 5th ed: WIley-Blackwell; 2009. p. 3–15.
93. Clippinger AJ, Bouchard MJ, Hepatitis B virus HBx protein localizes to mitochondria in primary rat hepatocytes and modulates mitochondrial membrane potential. Journal of virology. 2008;82(14):6798–811. Epub 2008/05/02. doi: 10.1128/JVI.00154-0818448529
94. Seglen P, Isolation of hepatocytes by collagenase perfusion. Methods in Toxicology. 11993. p. 231–43.
95. Bouchard MJ, Wang LH, Schneider RJ, Calcium signaling by HBx protein in hepatitis B virus DNA replication. Science. 2001;294(5550):2376–8. 11743208
96. Andrews S, FastQC. Babraham Institute; 2014.
97. Li H, Durbin R, Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25(14):1754–60. doi: 10.1093/bioinformatics/btp32419451168
98. Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15–21. doi: 10.1093/bioinformatics/bts63523104886
99. Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL, TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome biology. 2013;14(4):R36. doi: 10.1186/gb-2013-14-4-r3623618408
100. Langmead B, Salzberg SL, Fast gapped-read alignment with Bowtie 2. Nature methods. 2012;9(4):357–9. doi: 10.1038/nmeth.192322388286
101. Tarasov A, Vilella AJ, Cuppen E, Nijman IJ, Prins P, Sambamba: fast processing of NGS alignment formats. Bioinformatics. 2015.
102. Team RCR: A language and environment for statistical computing. R Foundation for Statistical Computing; 2014.
103. Morgan M, Pages H, Obenchain V, Hayden N. Rsamtools: Binary alignment (BAM), FASTA, variant call (BCF), and tabix file import.
104. Lawrence M, Huber W, Pages H, Aboyoun P, Carlson M, Gentleman R, et al. Software for computing and annotating genomic ranges. PLoS computational biology. 2013;9(8):e1003118. doi: 10.1371/journal.pcbi.100311823950696
105. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B, Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nature methods. 2008;5(7):621–8. doi: 10.1038/nmeth.122618516045
106. Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR, et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nature protocols. 2012;7(3):562–78. doi: 10.1038/nprot.2012.01622383036
107. Love MI, Huber W, Anders S, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome biology. 2014;15(12):550. 25516281
108. Anders S, Huber W, Differential expression analysis for sequence count data. Genome biology. 2010;11(10):R106. doi: 10.1186/gb-2010-11-10-r10620979621
109. Robinson MD, McCarthy DJ, Smyth GK, edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139–40. doi: 10.1093/bioinformatics/btp61619910308
110. Benjamini Y, Hochberg Y, Controlling the False Discovery Rate—a Practical and Powerful Approach to Multiple Testing. J Roy Stat Soc B Met. 1995;57(1):289–300.
111. Oliveros JC, VENNY. An interactive tool for comparing lists with Venn Diagrams. 2007. Available from: http://bioinfogp.cnb.csic.es/tools/venny/index.html.
112. Wickham H, ggplot2: elegant graphics for data analysis: SpringerNew York; 2009.
113. Quinlan AR, Hall IM, BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics. 2010;26(6):841–2. doi: 10.1093/bioinformatics/btq03320110278
114. Kasprzyk A, BioMart: driving a paradigm change in biological data management. Database (Oxford). 2011;2011:bar049.
115. Del Sorbo MR, Balzano W, Donato M, Draghici S, Assessing co-regulation of directly linked genes in biological networks using microarray time series analysis. Biosystems. 2013;114(2):149–54. doi: 10.1016/j.biosystems.2013.07.00623876997